Elias Jabbour, MD

Management of Patients with R-R Acute Lymphocytic Leukemia. Role of MoAb

Elias Jabbour , MD;

08/29/2020

ALL– Management of Ph-positive and Ph-like ALL in 2020

Elias Jabbour , MD;

08/29/2020

Debate: Approaches for the Patient With Relapsed ALL: Novel Antibodies-Based Therapy

Elias Jabbour , MD;

03/09/2020

Management of Ph+ and Ph-like ALL

Elias Jabbour , MD;

03/09/2020

Videos

Exploring Chemotherapy-Free Treatment for Patients With Philadelphia-Positive ALL

11/07/2023

Elias Jabbour , MD;

At the 2023 Lymphoma, Leukemia & Myeloma Congress, Elias Jabbour, MD, discusses if chemotherapy can be eliminated from the treatment of Philadelphia-positive acute lymphoblastic leukemia.

At the 2023 Lymphoma, Leukemia &...

11/07/2023

Lymphoma, Leukemia & Myeloma Network

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Elias Jabbour, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products